Over the past 40 years, there have been major dermatological breakthroughs that have changed the way doctors treat patients, along with the very treatments they use.
A small study examines platelet-rich plasma injection as alternative or adjuvant melasma treatment.
Patients with pigmentary disorders suffer high frequency of psychological disturbances, including anxiety and depression.
New options may be possible for treatment-resistant and severe rosacea with the use of IL-17 inhibitors as researchers conduct studies on effectiveness.
Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.
Niki Vora reflects on how her struggles with untreated atopic dermatitis, folliculitis and cystic acne led her to writing her scholarship-winning essay.
Topicals aimed at reviving estrogen-deficient skin and warding off damage from UV rays hours after exposure, while repairing DNA, are among the new cosmeceutical innovations backed by science.
Although most skincare innovations happen in the medically dispensed lines before mass market availability, Dr. Vivian Bucay points out that there are lower priced options backed by science that dermatologists can confidently recommend to patients looking for effective skincare products.
Are there effective hyperhidrosis treatments that patients can better afford and tolerate? Dr. Jisun Cha discusses practical points of diagnosis and treatment.
Are your patients happy with their current acne treatment? These five new therapeutic options could offer better results, according to several studies.